药品“专利悬崖”国内外企业的应对策略研究

Patent cliff and patent coping strategy of the domestic and foreign enterprises

跨国制药企业大量专利药到期,给中国仿制药发展带来机遇。但跨国医药企业通过延长专利保护期、直接参与仿制药竞争等措施给国内仿制药企业设置了障碍。本文对未来几年里跨国企业即将到期的原研药专利状况进行了梳理,对跨国医药企业避免专利药到期影响,保护市场竞争地位的措施进行了分析,并提出了中国仿制药企业应对专利到期的专利策略。

The patent cliff of brand-name drugs brings big business opportunities to Chinese pharmaceutical enterprises. However,multinational pharmaceutical enterprises constitute barrier for the domestic enterprises by extending the duration of patent rights,directly producing generic drug and so on. In this article,the situation of expired patents of the brand-name drugs in the few years was presented. Also the measures of multinational pharmaceutical enterprises to reduce the impact of patent cliff were studied. Furthermore the strategies for domestic enterprises to grasp the big opportunities were proposed.